Clinical Trial

Biologic Characterization of Patients With ITP

Recruiting
View on ClinicalTrials.gov →
Summary
This is a no-profit, multicenter, biological, non-pharmacologic study aimed to characterize from a biological point of view previously untreated primary ITP patients. To this end, peripheral blood, fecal and bone marrow samples will be collected at baseline and at 30 days and 180 days after treatment initiation - for each line of therapy - and the results of the biological analysis performed at each time point will then be compared.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-12.
Status change: Not Yet Recruiting → Recruiting 2024-05-20
Trial Details
NCT Number NCT05694325
Lead Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions Immune Thrombocytopenia
Enrollment 200 participants
Start Date 2023-11-27
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2024-05-21